Research signals
Watch for GLP-1 receptor agonists, dual agonists, bariatric outcomes, inflammation, insulin resistance, and long-term safety.
Topic feed
Track research on obesity, appetite regulation, incretin therapy, adipose biology, metabolic complications, prevention, and public health.
Watch for GLP-1 receptor agonists, dual agonists, bariatric outcomes, inflammation, insulin resistance, and long-term safety.
Try obesity diabetes, adipose inflammation, weight loss maintenance, or obesity pharmacotherapy.